$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Modulation of Apoptosis and Differentiation by the Treatment of Sulfasalazine in Rabbit Articular Chondrocytes 원문보기

Toxicological research, v.32 no.2, 2016년, pp.115 - 121  

Lee, Won Kil (Department of Biomedical Laboratory Science, Namseoul University) ,  Kang, Jin Seok (Department of Biomedical Laboratory Science, Namseoul University)

Abstract AI-Helper 아이콘AI-Helper

This study was conducted to examine the cellular regulatory mechanisms of sulfasalazine (SSZ) in rabbit articular chondrocytes treated with sodium nitroprusside (SNP). Cell phenotype was determined, and the MTT assay, Western blot analysis and immunofluorescence staining of type II collagen was perf...

주제어

AI 본문요약
AI-Helper 아이콘 AI-Helper

* AI 자동 식별 결과로 적합하지 않은 문장이 있을 수 있으니, 이용에 유의하시기 바랍니다.

문제 정의

  • However, the molecular mechanism of cartilage degeneration is largely unknown (5,19,20). The aim of this study was to understand the basic molecular mechanism of cartilage degeneration, which is important for therapy in patients with degenerative cartilage disease
  • The purpose of this study was to examine the RA cellular regulatory mechanisms via SSZ in rabbit articular chondrocytes. Other studies have provided cell signaling information by identifying the cellular control mechanisms.
본문요약 정보가 도움이 되었나요?

참고문헌 (49)

  1. 1 Hadjigogos K 2003 The role of free radicals in the pathogenesis of rheumatoid arthritis Panminerva Med 45 7 13 12682616 

  2. 2 Harris ED Jr Faulkner CS 2nd Brown FE 1975 Collagenolytic systems in rheumatoid arthritis Clin Orthop Relat Res 110 303 316 10.1097/00003086-197507000-00041 168997 

  3. 3 Dai SM Shan ZZ Xu H Nishioka K 2007 Cellular targets of interleukin-18 in rheumatoid arthritis Ann Rheum Dis 66 1411 1418 10.1136/ard.2006.067793 2111635 --> 17502360 

  4. 4 Otero M Goldring MB 2007 Cells of the synovium in rheumatoid arthritis Arthritis Res Ther 9 220 10.1186/ar2292 18001488 

  5. 5 Scott DL Wolfe F Huizinga TW 2010 Rheumatoid arthritis Lancet 376 1094 1108 10.1016/S0140-6736(10)60826-4 20870100 

  6. 6 Abramson SB Amin A 2002 Blocking the effects of IL-1 in rheumatoid arthritis protects bone and cartilage Rheumatology (Oxford) 41 972 980 10.1093/rheumatology/41.9.972 12209029 

  7. 7 Carrillo Gutiérrez OY Pérez Sánchez AG Medina Serriteño N Rodríguez Orozco AR 2007 Side effects of COX-2 selective inhibitors. Critic related with its administration in patients with rheumatoid arthritis and osteoarthritis Rev Alerg Mex 54 116 122 18297851 

  8. 8 Chen YF Jobanputra P Barton P Bryan S Fry-Smith A Harris G Taylor RS 2008 Cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs (etodolac, meloxicam, celecoxib, rofecoxib, etoricoxib, valdecoxib and lumiracoxib) for osteoarthritis and rheumatoid arthritis: a systematic review and economic evaluation Health Technol Assess 12 1 278 10.3310/hta12110 18405470 

  9. 9 Shiozawa S Tokuhisa T 1992 Contribution of synovial mesenchymal cells to the pathogenesis of rheumatoid arthritis Semin Arthritis Rheum 21 267 273 10.1016/0049-0172(92)90058-L 1570520 

  10. 10 Tutuncu Z Kavanaugh A 2007 Rheumatic disease in the elderly: rheumatoid arthritis Rheum Dis Clin North Am 33 57 70 10.1016/j.rdc.2006.12.006 17367692 

  11. 11 Vergunst CE van de Sande MG Lebre MC Tak PP 2005 The role of chemokines in rheumatoid arthritis and osteoarthritis Scand J Rheumatol 34 415 425 10.1080/03009740500439159 16393761 

  12. 12 Combe B 1998 Inflammation and joint destruction during rheumatoid polyarthritis: what relation? Presse Med 27 481 483 9767983 

  13. 13 Häuselmann HJ 1997 Mechanisms of cartilage destruction and novel nonsurgical therapeutic strategies to retard cartilage injury in rheumatoid arthritis Curr Opin Rheumatol 9 241 250 10.1097/00002281-199705000-00011 9204260 

  14. 14 Meyer O 2000 Role of anti-TNF therapy in rheumatoid arthritis Presse Med 29 463 468 10745935 

  15. 15 Reines BP 2004 Is rheumatoid arthritis premature osteoarthritis with fetal-like healing? Autoimmun Rev 3 305 311 10.1016/j.autrev.2003.11.002 15246027 

  16. 16 Kastrinaki MC Papadaki HA 2009 Mesenchymal stromal cells in rheumatoid arthritis: biological properties and clinical applications Curr Stem Cell Res Ther 4 61 69 10.2174/157488809787169084 19149631 

  17. 17 Lombardi A Pignone A Perfetto F Tarquini R Partsch G Matucci-Cerinic M 1993 The enzymatic mechanisms involved in the pathogenesis of rheumatoid arthritis and arthrosis. The role of metalloproteases and serine proteases in the breakdown of articular cartilage Recenti Prog Med 84 634 641 8210629 

  18. 18 Shiozawa S Shiozawa K 1988 A review of the histopathological evidence on the pathogenesis of cartilage destruction in rheumatoid arthritis Scand J Rheumatol Suppl 74 65 72 10.3109/03009748809102940 3068794 

  19. 19 Bouffi C Djouad F Mathieu M Noël D Jorgensen C 2009 Multipotent mesenchymal stromal cells and rheumatoid arthritis: risk or benefit? Rheumatology (Oxford) 48 1185 1189 10.1093/rheumatology/kep162 19561159 

  20. 20 Magliano M 2008 Obesity and arthritis Menopause Int 14 149 154 19037063 

  21. 21 Amin AR Abramson SB 1998 The role of nitric oxide in articular cartilage breakdown in osteoarthritis Curr Opin Rheumatol 10 263 268 10.1097/00002281-199805000-00018 9608331 

  22. 22 Martel-Pelletier J Alaaeddine N Pelletier JP 1999 Cytokines and their role in the pathophysiology of osteoarthritis Front Biosci 4 D694 D703 10.2741/Martel 10525480 

  23. 23 Blanco FJ Guitian R Vázquez-Martul E de Toro FJ Galdo F 1998 Osteoarthritis chondrocytes die by apoptosis. A possible pathway for osteoarthritis pathology Arthritis Rheum 41 284 289 10.1002/1529-0131(199802)41:2 3.0.CO;2-T 9485086 

  24. 24 Hashimoto S Ochs RL Komiya S Lotz M 1998 Linkage of chondrocyte apoptosis and cartilage degradation in human osteoarthritis Arthritis Rheum 41 1632 1638 10.1002/1529-0131(199809)41:9 3.0.CO;2-A 9751096 

  25. 25 Yatsugi N Tsukazaki T Osaki M Koji T Yamashita S Shindo H 2000 Apoptosis of articular chondrocytes in rheumatoid arthritis and osteoarthritis: correlation of apoptosis with degree of cartilage destruction and expression of apoptosis-related proteins of p53 and c-myc J Orthop Sci 5 150 156 10.1007/s007760050142 10982649 

  26. 26 Cao M Westerhausen-Larson A Niyibizi C Kavalkovich K Georgescu HI Rizzo CF Hebda PA Stefanovic-Racic M Evans CH 1997 Nitric oxide inhibits the synthesis of type-II collagen without altering Col2A1 mRNA abundance: prolyl hydroxylase as a possible target Biochem J 324 305 310 10.1042/bj3240305 1218431 --> 9164871 

  27. 27 Taskiran D Stefanovic-Racic M Georgescu H Evans C 1994 Nitric oxide mediates suppression of cartilage proteoglycan synthesis by interleukin-1 Biochem Biophys Res Commun 200 142 148 10.1006/bbrc.1994.1426 7513156 

  28. 28 Kim SJ Hwang SG Shin DY Kang SS Chun JS 2002 p38 kinase regulates nitric oxide-induced apoptosis of articular chondrocytes by accumulating p53 via NFκB-dependent transcription and stabilization by serine 15 phosphorylation J Biol Chem 277 33501 33508 10.1074/jbc.M202862200 12091386 

  29. 29 Kim SJ Ju JW Oh CD Yoon YM Song WK Kim JH Yoo YJ Bang OS Kang SS Chun JS 2002 ERK-1/2 and p38 kinase oppositely regulate nitric oxide-induced apoptosis of chondrocytes in association with p53, caspase-3, and differentiation status J Biol Chem 277 1332 1339 10.1074/jbc.M107231200 11689560 

  30. 30 Kim SJ Kim HG Oh CD Hwang SG Song WK Yoo YJ Kang SS Chun JS 2002 p38 kinase-dependent and -independent Inhibition of protein kinase C ζ and -α regulates nitric oxide-induced apoptosis and dedifferentiation of articular chondrocytes J Biol Chem 277 30375 30381 10.1074/jbc.M205193200 12048219 

  31. 31 Klotz U 1985 Clinical efficacy of oral 5-aminosalicylic acid in the treatment of inflammatory bowel disease Am J Gastroenterol 80 660 4025285 

  32. 32 Peppercorn MA 1984 Sulfasalazine. Pharmacology, clinical use, toxicity, and related new drug development Ann Intern Med 101 377 386 10.7326/0003-4819-101-3-377 6147110 

  33. 33 Astbury C Taggart AJ Juby L Zebouni L Bird HA 1990 Comparison of the single dose pharmacokinetics of sulphasalazine in rheumatoid arthritis and inflammatory bowel disease Ann Rheum Dis 49 587 590 10.1136/ard.49.8.587 1004169 --> 1975737 

  34. 34 Plosker GL Croom KF 2005 Sulfasalazine: a review of its use in the management of rheumatoid arthritis Drugs 65 1825 1849 10.2165/00003495-200565130-00008 16114981 

  35. 35 Azadkhan AK Truelove SC Aronson JK 1982 The disposition and metabolism of sulphasalazine (salicylazosulphapyridine) in man Br J Clin Pharmacol 13 523 528 10.1111/j.1365-2125.1982.tb01415.x 1402052 --> 6121576 

  36. 36 Klotz U Schwab M 2005 Topical delivery of therapeutic agents in the treatment of inflammatory bowel disease Adv Drug Deliv Rev 57 267 279 10.1016/j.addr.2004.08.007 15555742 

  37. 37 Friedman G 1986 Sulfasalazine and new analogues Am J Gastroenterol 81 141 144 2868653 

  38. 38 Klotz U 1985 Clinical pharmacokinetics of sulphasalazine, its metabolites and other prodrugs of 5-aminosalicylic acid Clin Pharmacokinet 10 285 302 10.2165/00003088-198510040-00001 2864155 

  39. 39 van Hees PA Bakker JH van Tongeren JH 1980 Effect of sulphapyridine, 5-aminosalicylic acid, and placebo in patients with idiopathic proctitis: a study to determine the active therapeutic moiety of sulphasalazine Gut 21 632 635 10.1136/gut.21.7.632 1419886 --> 6107263 

  40. 40 Yazdanian M Glynn SL Wright JL Hawi A 1998 Correlating partitioning and Caco-2 cell permeability of structurally diverse small molecular weight compounds Pharm Res 15 1490 1494 10.1023/A:1011930411574 9755906 

  41. 41 Yoon YM Kim SJ Oh CD Ju JW Song WK Yoo YJ Huh TL Chun JS 2002 Maintenance of differentiated phenotype of articular chondrocytes by protein kinase C and extracellular signal-regulated protein kinase J Biol Chem 277 8412 8420 10.1074/jbc.M110608200 11744731 

  42. 42 Ryu JH Kim SJ Kim SH Oh CD Hwang SG Chun CH Oh SH Seong JK Huh TL Chun JS 2002 Regulation of the chondrocyte phenotype by β-catenin Development 129 5541 5550 10.1242/dev.00110 12403723 

  43. 43 Poole AR 2003 Cartilage in health and disease in Arthritis and Allied Conditions McCarthy DJ Koopman WJ Lea and Febiger Philadelphia 279 333 

  44. 44 Goldring MB Birkhead J Sandell LJ Kimura T Krane SM 1988 Interleukin 1 suppresses expression of cartilage-specific types II and IX collagens and increases types I and III collagens in human chondrocytes J Clin Invest 82 2026 2037 10.1172/JCI113823 442785 --> 3264290 

  45. 45 Benya PD Padilla SR Nimni ME 1978 Independent regulation of collagen types by chondrocytes during the loss of differentiated function in culture Cell 15 1313 1321 10.1016/0092-8674(78)90056-9 729001 

  46. 46 Gay S Gay RE Koopman WJ 1993 Molecular and cellular mechanisms of joint destruction in rheumatoid arthritis: two cellular mechanisms explain joint destruction? Ann Rheum Dis 52 S39 S47 10.1136/ard.52.Suppl_1.S39 1035025 --> 8481058 

  47. 47 Sandell LJ Aigner T 2001 Articular cartilage and changes in arthritis. An introduction: cell biology of osteoarthritis Arthritis Res 3 107 113 10.1186/ar148 128887 --> 11178118 

  48. 48 Myers LK Kang AH Postlethwaite AE Rosloniec EF Morham SG Shlopov BV Goorha S Ballou LR 2000 The genetic ablation of cyclooxygenase 2 prevents the development of autoimmune arthritis Arthritis Rheum 43 2687 2693 10.1002/1529-0131(200012)43:12 3.0.CO;2-9 11145026 

  49. 49 Oh CD Chang SH Yoon YM Lee SJ Lee YS Kang SS Chun JS 2000 Opposing role of mitogen-activated protein kinase subtypes, erk-1/2 and p38, in the regulation of chondrogenesis of mesenchymes J Biol Chem 275 5613 5619 10.1074/jbc.275.8.5613 10681543 

저자의 다른 논문 :

관련 콘텐츠

오픈액세스(OA) 유형

GOLD(Hybrid)

저자가 APC(Article Processing Charge)를 지불한 논문에 한하여 자유로운 이용이 가능한, hybrid 저널에 출판된 논문

저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로